A Placebo-Controlled, Double-Blind, Randomized, Cross Over Pilot Study Of The Efficacy And Tolerability Of Incobotulinum Toxin A (Xeomin) As A Treatment For Focal Task-Specific Dystonia Of The Musician's Hand

Trial Profile

A Placebo-Controlled, Double-Blind, Randomized, Cross Over Pilot Study Of The Efficacy And Tolerability Of Incobotulinum Toxin A (Xeomin) As A Treatment For Focal Task-Specific Dystonia Of The Musician's Hand

Recruiting
Phase of Trial: Phase II

Latest Information Update: 23 Sep 2016

At a glance

  • Drugs Botulinum toxin A (Primary)
  • Indications Dystonia
  • Focus Therapeutic Use
  • Most Recent Events

    • 14 Sep 2016 Planned End Date changed from 1 Dec 2017 to 1 Jun 2018.
    • 14 Sep 2016 Planned primary completion date changed from 1 Dec 2016 to 1 Jun 2018.
    • 30 Jun 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top